Teladoc Health (NYSE:TDOC) Hits New 12-Month Low at $13.54

Teladoc Health, Inc. (NYSE:TDOC) shares reached a new 52-week low on Monday . The company traded as low as $13.54 and last traded at $13.57, with a volume of 3128879 shares traded. The stock had previously closed at $14.21.

Wall Street Analysts Forecast Growth

A number of analysts have commented on TDOC shares. Truist Financial cut their price objective on shares of Teladoc Health from $23.00 to $17.00 and set a “hold” rating for the company in a report on Wednesday, March 6th. Citigroup dropped their target price on Teladoc Health from $21.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, February 21st. Royal Bank of Canada reduced their price target on Teladoc Health from $30.00 to $25.00 and set an “outperform” rating on the stock in a report on Wednesday, February 21st. Leerink Partnrs restated a “market perform” rating on shares of Teladoc Health in a research report on Monday, February 26th. Finally, SVB Leerink began coverage on shares of Teladoc Health in a research note on Monday, February 26th. They set a “market perform” rating and a $17.00 target price on the stock. Eight equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $22.23.

Teladoc Health Price Performance

The company has a market capitalization of $2.24 billion, a PE ratio of -9.80 and a beta of 0.94. The company has a debt-to-equity ratio of 0.66, a current ratio of 3.54 and a quick ratio of 3.47. The stock’s 50 day simple moving average is $16.02 and its 200-day simple moving average is $18.02.

Teladoc Health (NYSE:TDOC) last released its earnings results on Tuesday, February 20th. The health services provider reported ($0.17) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.05. The company had revenue of $660.50 million for the quarter, compared to analyst estimates of $670.79 million. Teladoc Health had a negative net margin of 8.47% and a negative return on equity of 9.22%. The firm’s quarterly revenue was up 3.6% on a year-over-year basis. During the same period in the prior year, the business earned ($0.23) EPS. As a group, equities analysts forecast that Teladoc Health, Inc. will post -1.07 earnings per share for the current fiscal year.

Insider Activity

In related news, CAO Richard J. Napolitano sold 3,765 shares of Teladoc Health stock in a transaction on Monday, March 4th. The shares were sold at an average price of $14.52, for a total transaction of $54,667.80. Following the sale, the chief accounting officer now directly owns 18,077 shares in the company, valued at approximately $262,478.04. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CAO Richard J. Napolitano sold 3,765 shares of the firm’s stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $54,667.80. Following the transaction, the chief accounting officer now owns 18,077 shares in the company, valued at approximately $262,478.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Andrew Turitz sold 6,190 shares of the business’s stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $89,878.80. Following the completion of the sale, the executive vice president now owns 39,429 shares of the company’s stock, valued at approximately $572,509.08. The disclosure for this sale can be found here. In the last quarter, insiders sold 134,441 shares of company stock worth $2,025,041. 1.63% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Forum Financial Management LP grew its holdings in shares of Teladoc Health by 14.4% during the first quarter. Forum Financial Management LP now owns 3,094 shares of the health services provider’s stock worth $223,000 after buying an additional 390 shares during the last quarter. Parallel Advisors LLC grew its stake in shares of Teladoc Health by 14.6% in the 4th quarter. Parallel Advisors LLC now owns 4,038 shares of the health services provider’s stock valued at $87,000 after purchasing an additional 515 shares during the last quarter. Canada Pension Plan Investment Board increased its holdings in shares of Teladoc Health by 21.6% in the first quarter. Canada Pension Plan Investment Board now owns 2,900 shares of the health services provider’s stock valued at $209,000 after purchasing an additional 515 shares during the period. Mariner LLC raised its stake in shares of Teladoc Health by 2.7% during the fourth quarter. Mariner LLC now owns 19,877 shares of the health services provider’s stock worth $470,000 after purchasing an additional 525 shares during the last quarter. Finally, M&T Bank Corp lifted its holdings in shares of Teladoc Health by 5.5% during the fourth quarter. M&T Bank Corp now owns 11,152 shares of the health services provider’s stock worth $241,000 after purchasing an additional 584 shares during the period. 76.82% of the stock is currently owned by institutional investors and hedge funds.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.